Hepatitis C trials in China

2 of 2 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• No phaseTaking people
  The Efficacy of Vosevi in Treating DAA-experienced Patients

  Where

  Guangzhou

  Age

  20 years to 70 years

  People

  200

  Run by

  The Third Affiliated Hospital of Guangzhou Medical University

  See details and how to joinNCT06180590
• No phaseTaking people
  Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH)

  Where

  Shanghai

  Age

  18 years to 75 years

  People

  20,000

  Run by

  Ruijin Hospital

  See details and how to joinNCT05870969